Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Help & Advice
University of Warwick

The Library

  • Login
  • Admin

Cell-based therapies for stroke : promising solution or dead end?

Tools
- Tools
+ Tools

Boltze, Johannes, Abe, Koji, Clarkson, Andrew N., Detante, Olivier, Pimentel-Coelho, Pedro M., Rosado-de-Castro, Paulo H. and Janowski, Miroslaw (2020) Cell-based therapies for stroke : promising solution or dead end? Frontiers in Neurology, 11 . 171. doi:10.3389/fneur.2020.00171 ISSN 1664-2295.

[img]
Preview
PDF
WRAP-cell-based-therapies-stroke-promising-solution-Boltze-2020.pdf - Accepted Version - Requires a PDF viewer.
Available under License Creative Commons Attribution 4.0.

Download (747Kb) | Preview
Official URL: https://doi.org/10.3389/fneur.2020.00171

Request Changes to record.

Abstract

The introduction of recanalization procedures has revolutionized acute stroke management, although the narrow time window, strict eligibility criteria and logistical limitations still exclude the majority of patients from treatment. In addition, residual deficits are present in many patients who undergo therapy, preventing their return to premorbid status. Hence, there is a strong need for novel, and ideally complementary, approaches to stroke management.
In preclinical experiments, cell-based treatments have demonstrated beneficial effects in the subacute and chronic stages following stroke [1; 2; 3] and therefore are considered a promising option to supplement current clinical practice. At the same time, great progress has been made in developing clinically feasible delivery and monitoring protocols [4]. However, efficacy results initially reported in clinical studies fell short of expectations [5] raising concerns that cell treatment might eventually share the ‘dead end fate’ of many previous experimental stroke therapies. This Research Topic reviews some of the latest and most innovative studies to summarize the state of the art in translational cell treatments for stroke.

Item Type: Journal Article
Alternative Title:
Subjects: Q Science > QH Natural history
R Medicine > RC Internal medicine
Divisions: Faculty of Science, Engineering and Medicine > Science > Life Sciences (2010- )
Library of Congress Subject Headings (LCSH): Stem cells , Mesenchymal stem cells , Cerebrovascular disease , Cerebrovascular disease -- Treatment
Journal or Publication Title: Frontiers in Neurology
Publisher: Frontiers Research Foundation
ISSN: 1664-2295
Official Date: 3 April 2020
Dates:
DateEvent
3 April 2020Published
March 2020Available
24 February 2020Accepted
Volume: 11
Article Number: 171
DOI: 10.3389/fneur.2020.00171
Status: Peer Reviewed
Publication Status: Published
Access rights to Published version: Open Access (Creative Commons)
Date of first compliant deposit: 6 March 2020
Date of first compliant Open Access: 11 March 2020
Related URLs:
  • Publisher

Request changes or add full text files to a record

Repository staff actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics

twitter

Email us: wrap@warwick.ac.uk
Contact Details
About Us